QUESTION ONE – VTE RISK ASSESSMENT AND DIAGNOSIS
a) Are in-patients who are considered to be at risk of VTE in your Trust routinely checked for both proximal and distal DVT? (Tick one box)
b) For in-patients diagnosed with VTE in your Trust between 1 April 2018 and 31 March 2019, what was the average time from first clinical suspicion of VTE to diagnosis?
c) For in-patients diagnosed with VTE in your Trust between 1 April 2018 and 31 March 2019, what was the average time from diagnosis to first treatment?
QUESTION TWO – ROOT CAUSE ANALYSIS OF HOSPITAL-ASSOCIATED THROMBOSIS
According to Service Condition 22 of the NHS Standard Contract 2017/19, the provider must:
“Perform Root Cause Analysis of all confirmed cases of pulmonary embolism and deep vein thrombosis acquired by Service Users while in hospital (both arising during a current hospital stay and where there is a history of hospital admission within the last 3 months, but not in respect of Service Users admitted to hospital with a confirmed venous thromboembolism but no history of an admission to hospital within the previous 3 months)…”
The provider must report the results of those Root Cause Analyses to the co-ordinating commissioner on a monthly basis.
a) How many cases of hospital-associated thrombosis (HAT) were recorded in your Trust in each of the following quarters?
b) How many Root Cause Analyses of confirmed cases of HAT were performed in each of the following quarters?
c) According to the Root Cause Analyses of confirmed HAT in your Trust between 1 April 2018 and 31 March 2019, in how many cases:
QUESTION THREE – ADMISSION TO HOSPITAL FOR VTE
a) How many patients were admitted to your Trust for VTE which occurred outside of a secondary care setting between 1 April 2018 and 31 March 2019?
b) Of these patients, how many:
c) Of the patients admitted to your Trust for VTE occurring between 1 April 2018 and 31 March 2019 who had a previous inpatient stay in your Trust up to 90 days prior to their admission, how many had their VTE risk status recorded in their discharge summary?
d) Please describe how your Trust displays a patient’s VTE risk status in its discharge summaries.
QUESTION FOUR – PHARMACOLOGICAL VTE PROPHYLAXIS
a) How many VTE patients who were eligible received pharmacological VTE prophylaxis between 1 April 2018 and 31 March 2019?
b) How many of VTE patients who were eligible received pharmacological VTE prophylaxis within 14 hours of admission between 1 April 2018 and 31 March 2019?
QUESTION FIVE – VTE AND CANCER
a) How many patients has your Trust treated for cancer (of all types) in each of the past three years?
b) Of the patients treated for cancer, how many also had a diagnosis of venous thromboembolism (VTE) {VTE is defined by the following ICD 10 codes: I80.0-I80.3, I80.8-I80.9, I82.9, O22.2 – O22.3, O87.0 – O87.1, I26.0, and I26.9} in each of the past three years?
c) Of the patients treated for cancer who also had a diagnosis of VTE in each of the past three years, how many:
d) In how many patient deaths within your Trust was cancer (of any type) listed as the primary cause of death in each of the past three years:
e) Of the patients who died within your Trust, in how many was VTE as well as cancer listed as a cause of death in each of the past three years:
f) Of the patients who died in your Trust who had both VTE and cancer listed as a cause of death, how many:
g) Are ambulatory cancer patients who are receiving chemotherapy in your Trust routinely risk assessed for their risk of developing CAT/VTE?
h) Are ambulatory cancer patients who are receiving chemotherapy AND deemed at high risk of developing CAT/VTE offered pharmacological thromboprophylaxis with? Please tick/cross all those appropriate.
QUESTION SIX – PATIENT INFORMATION
The NICE Quality Standard on VTE Prevention stipulates that patients/carers should be offered verbal and written information on VTE prevention as part of the admission as well as the discharge processes.
a) What steps does your Trust take to ensure patients are adequately informed about VTE prevention? (Tick each box that applies)
b) If your Trust provides written information on VTE prevention, does it provide information in languages other than English? (Tick each box that applies)
QUESTION SEVEN – COST OF VTE IN YOUR AREA
a) Does your Trust have an estimate of the cost of VTE to the NHS locally (including cost of treatment, hospital bed days and litigation costs) for 2018/19? (Please tick one box)
If ‘Yes’, please specify the estimated cost:
b) Please indicate the cost-estimate for the following areas of VTE management and care, as well as the corresponding number of VTE hospitalisations/ re-admissions/ treatments that occurred between 1 April 2018 and 31 March 2016.
